Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1200
-
Total 13F shares, excl. options
-
215M
-
Shares change
-
-820K
-
Total reported value, excl. options
-
$80.4B
-
Value change
-
-$317M
-
Put/Call ratio
-
0.87
-
Number of buys
-
528
-
Number of sells
-
-499
-
Price
-
$372.80
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q3 2021
1,348 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q3 2021.
Elevance Health, Inc. - Common Stock (ELV) has 1,200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 215M shares
of 226M outstanding shares and own 95.34% of the company stock.
Largest 10 shareholders include BlackRock Inc. (21.7M shares), VANGUARD GROUP INC (18.9M shares), STATE STREET CORP (10.6M shares), WELLINGTON MANAGEMENT GROUP LLP (10.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.82M shares), FMR LLC (6.39M shares), Capital International Investors (5.2M shares), GEODE CAPITAL MANAGEMENT, LLC (4.12M shares), BAILLIE GIFFORD & CO (3.99M shares), and Sanders Capital, LLC (3.98M shares).
This table shows the top 1200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.